Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3851444 | American Journal of Kidney Diseases | 2009 | 10 Pages |
Abstract
Overall, a multistep treatment strategy consisting of pravastatin, vitamin E, and B vitamins had no effect on plasma ADMA levels in a stage 2 to 4 CKD population. This suggests that the beneficial effects of the intervention were not mediated by changes in ADMA levels. Possible ADMA-lowering effects of vitamin E deserve further attention.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Prabath W.B. MD, Jessica C. MSc, Piet M. MD, PhD, Coen D.A. MD, PhD, Frans J. MD, PhD, Margreet R. MSc, PhD, Tom MD, PhD, Jos W.R. MD, PhD, Coen MD, PhD, Yvo M. MD, PhD,